Tirzepatide attenuates lipopolysaccharide-induced left ventricular remodeling and dysfunction by inhibiting the TLR4/NF-kB/NLRP3 pathway
- 15 May 2023
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 120, 110311
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82070330, 82200348)
This publication has 27 references indexed in Scilit:
- Severe sepsis and cardiac arrhythmiasAnnals of Translational Medicine, 2018
- Interleukin-18 gene deletion protects against sepsis-induced cardiac dysfunction by inhibiting PP2A activityInternational Journal of Cardiology, 2017
- Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasomeNature Immunology, 2017
- Cytokine storm and sepsis disease pathogenesisSeminars in Immunopathology, 2017
- PPAR‐γ Activation Prevents Septic Cardiac Dysfunction via Inhibition of Apoptosis and NecroptosisOxidative Medicine and Cellular Longevity, 2017
- The emerging role of Toll-like receptor 4 in myocardial inflammationCell Death & Disease, 2016
- Inhibition of miR-155 Protects Against LPS-induced Cardiac Dysfunction and Apoptosis in MiceMolecular Therapy Nucleic Acids, 2016
- A review of sepsis-induced cardiomyopathyJournal of Intensive Care, 2015
- Sepsis definitions: time for changeThe Lancet, 2013
- Caspase Inhibition Prevents Cardiac Dysfunction and Heart Apoptosis in a Rat Model of SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2001